Literature DB >> 394674

Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique.

R E Desjardins, C J Canfield, J D Haynes, J D Chulay.   

Abstract

A rapid, semiautomated microdilution method was developed for measuring the activity of potential antimalarial drugs against cultured intraerythrocytic asexual forms of the human malaria parasite Plasmodium falciparum. Microtitration plates were used to prepare serial dilutions of the compounds to be tested. Parasites, obtained from continuous stock cultures, were subcultured in these plates for 42 h. Inhibition of uptake of a radiolabeled nucleic acid precursor by the parasites served as the indicator of antimalarial activity. Results of repeated measurements of activity with chloroquine, quinine, and the investigational new drug mefloquine demonstrated that the method is sensitive and precise. Several additional antimalarial drugs and compounds of interest were tested in vitro, and the results were consistent with available in vivo data. The use of P. falciparum isolates with known susceptibility to antimalarial drugs also permitted evaluation of the cross-resistance potential of each compound tested. The applications and expectations of this new test system within a drug development program are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 394674      PMCID: PMC352941          DOI: 10.1128/AAC.16.6.710

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  DRUG RESISTANCE IN PLASMODIUM FALCIPARUM FROM THAILAND.

Authors:  M D YOUNG; P G CONTACOS; J E STITCHER; J W MILLAR
Journal:  Am J Trop Med Hyg       Date:  1963-05       Impact factor: 2.345

2.  Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine.

Authors:  D V MOORE; J E LANIER
Journal:  Am J Trop Med Hyg       Date:  1961-01       Impact factor: 2.345

3.  Possible in vitro test for screening drugs for activity against Babesia and other blood protozoa.

Authors:  A D Irvin; E R Young
Journal:  Nature       Date:  1977-09-29       Impact factor: 49.962

4.  Chloroquine-resistant falciparum malaria from Africa.

Authors:  B H Kean
Journal:  JAMA       Date:  1979-01-26       Impact factor: 56.272

5.  Culture of human malaria parasites Plasmodium falciparum.

Authors:  J D Haynes; C L Diggs; F A Hines; R E Desjardins
Journal:  Nature       Date:  1976-10-28       Impact factor: 49.962

6.  Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique.

Authors:  K H Rieckmann; G H Campbell; L J Sax; J E Mrema
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

7.  Plasmodium falciparum and Plasmodium vivax infections in the owl monkey (Aotus trivirgatus). III. Methods employed in the search for new blood schizonticidal drugs.

Authors:  L H Schmidt
Journal:  Am J Trop Med Hyg       Date:  1978-07       Impact factor: 2.345

8.  Antimalarial activities of various 4-quinolonemethanols with special attention to WR-142,490 (mefloquine).

Authors:  L H Schmidt; R Crosby; J Rasco; D Vaughan
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

9.  Evaluation of two phenanthrenemethanols for antimalarial activity in man: WR 122,455 and WR 171,669.

Authors:  J Rinehart; J Arnold; C J Canfield
Journal:  Am J Trop Med Hyg       Date:  1976-11       Impact factor: 2.345

10.  Activities of various 4-aminoquinolines against infections with chloroquine-resistant strains of Plasmodium falciparum.

Authors:  L H Schmidt; D Vaughan; D Mueller; R Crosby; R Hamilton
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

View more
  574 in total

1.  Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.

Authors:  A Singh; P J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  In vitro activities of DU-1102, a new trioxaquine derivative, against Plasmodium falciparum isolates.

Authors:  L K Basco; O Dechy-Cabaret; M Ndounga; F S Meche; A Robert; B Meunier
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Histidine-rich protein II: a novel approach to malaria drug sensitivity testing.

Authors:  Harald Noedl; Walther H Wernsdorfer; Robert Scott Miller; Chansuda Wongsrichanalai
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

4.  Hematin polymerization assay as a high-throughput screen for identification of new antimalarial pharmacophores.

Authors:  Y Kurosawa; A Dorn; M Kitsuji-Shirane; H Shimada; T Satoh; H Matile; W Hofheinz; R Masciadri; M Kansy; R G Ridley
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

5.  Synergistic in vitro antimalarial activity of omeprazole and quinine.

Authors:  T Skinner-Adams; T M Davis
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

6.  16alpha-bromoepiandrosterone, an antimalarial analogue of the hormone dehydroepiandrosterone, enhances phagocytosis of ring stage parasitized erythrocytes: a novel mechanism for antimalarial activity.

Authors:  Kodjo Ayi; Giuliana Giribaldi; Aleksei Skorokhod; Evelin Schwarzer; Patrick T Prendergast; Paolo Arese
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 7.  Recent advances in malaria parasite cultivation and their application to studies on host-parasite relationships: a review.

Authors:  P I Trigg
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

8.  Development of an in vitro microtest for determining the susceptibility of Plasmodium falciparum to sulfadoxine-pyrimethamine: laboratory investigations and field studies in Port-au-Prince, Haiti.

Authors:  P Nguyen-Dinh; D Payne; A Teklehaimanot; A Zevallos-Ipenza; M M Day; Y T Duverseau
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

9.  In vitro activities of and mechanisms of resistance to antifol antimalarial drugs.

Authors:  W K Milhous; N F Weatherly; J H Bowdre; R E Desjardins
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

10.  Serotypes of Plasmodium falciparum defined by immune serum inhibition of in vitro growth.

Authors:  J D Chulay; J D Haynes; C L Diggs
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.